Latest Articles

Publication Date
All News Scientific
Ibuprofen: How an everyday drug might offer protection against cancer - Medical Xpress

Ibuprofen: How an everyday drug might offer protection against cancer Medical Xpress

Published: Oct. 19, 2025, 4:30 p.m.
Read Full Article
Dydrogesterone Drug Market expected to grow from USD 846.3 Million in 2025 to USD 1,500 Million by 2035 - industrytoday.co.uk

Dydrogesterone Drug Market expected to grow from USD 846.3 Million in 2025 to USD 1,500 Million by 2035 industrytoday.co.uk

Published: Oct. 19, 2025, 11:06 a.m.
Read Full Article
Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness - Oncodaily

Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness Oncodaily

Published: Oct. 18, 2025, 9:25 p.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Read Full Article
Dylan Sprouse reveals wife Barbara Palvin walked 2025 Victoria’s Secret Fashion Show on broken foot months after endometriosis surgery - AOL.com

Dylan Sprouse reveals wife Barbara Palvin walked 2025 Victoria’s Secret Fashion Show on broken foot months after endometriosis surgery AOL.com

Published: Oct. 18, 2025, 11:13 a.m.
Read Full Article
Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias - Free Press Journal

Dylan Sprouse Supports Wife Barbara Palvins Health Condition By Wearing Yellow Ribbon Pin At Victorias Free Press Journal

Published: Oct. 18, 2025, 11 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Yahoo Finance

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Yahoo Finance

Published: Oct. 18, 2025, 10 a.m.
Read Full Article
The best October Prime Day 2025 Satisfyer deals - Mashable

The best October Prime Day 2025 Satisfyer deals Mashable

Published: Oct. 18, 2025, 8:13 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!